DUSP1 and neoplasm: The limited data available to date suggest that DUSP1 dysregulation in tumors can lead to varied outcomes, including tumorigenesis, tumor progression, chemoresistance, radioresistance, immune escape, and tumor recurrence; however, in select cases, it can also have tumor-suppressing properties.